<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Multidisciplinary Cancer Investigation</title>
<title_fa>نشریه بین المللی چند تخصصی سرطان</title_fa>
<short_title>Multidiscip Cancer Investig</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mcijournal.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2476-4922</journal_id_issn>
<journal_id_issn_online>2538-1911</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/mci</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>1</volume>
<number>Supplement Issue 1: Abstracts of International Tehran Breast Cancer Congress</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Applications of the CRISPR-Cas9 System in
Generation of Model Cell Lines for Cancer Biology</title>
	<subject_fa></subject_fa>
	<subject>Materials Science and Nanomedicine</subject>
	<content_type_fa></content_type_fa>
	<content_type>Original/Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Introduction: Cancer is known to be the second leading cause of death in the world after&lt;br&gt;
the cardiovascular disease. Therefore, it is important to study the various factors involved&lt;br&gt;
in cancer. In this regard, animal and cell models can be used to examine the different stages&lt;br&gt;
of cancer, as well as its prevention and treatment. In the present study, we tried to stablish a&lt;br&gt;
genome editing pipeline to generate genome edited cancer cell lines using CRISPR CAS9&lt;br&gt;
technology.&lt;br&gt;
Materials and Methods: We seeded about 40,000 cells in a 4-well plate and transfected&lt;br&gt;
CRISPR CAS9 constructs by PEI to A549 cells on the next day followed by a brief selection&lt;br&gt;
with puromycin. We allowed the remaining cells to multiply and form colonies then&lt;br&gt;
we separated and transferred them in new plates using ring cloning method. On the obtained&lt;br&gt;
colonies, we examined the function of the CRISPR, precisely designed the primer&lt;br&gt;
for the CRISPR target area and sequenced the PCR product.&lt;br&gt;
Results: In our study, we were able to colonize CRISPR-modified single cells and propagate&lt;br&gt;
them into permanent cell lines harboring the modified CRISPR target. Using transient&lt;br&gt;
expression of the antibiotic resistance gene, we successfully enriched the colonies with genome&lt;br&gt;
modified clones to obtain a higher efficiency.&lt;br&gt;
Conclusions: Proposed method provides a convenient means to generate different genome-&lt;br&gt;
edited cancer cell lines which can be used to study the function of any candidate&lt;br&gt;
gene in various stages of cancer, including metastasis, which plays a major role in increasing&lt;br&gt;
mortality in cancer patients.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cancer
Cell Line
CRISPR CAS9</keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url>http://mcijournal.com/browse.php?a_code=A-10-33-40&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Hossein </first_name>
	<middle_name></middle_name>
	<last_name>Arabameri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600726</code>
	<orcid>1003194753284600726</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saghar </first_name>
	<middle_name></middle_name>
	<last_name>Pahlavanneshan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600727</code>
	<orcid>1003194753284600727</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahmood </first_name>
	<middle_name></middle_name>
	<last_name>Tavallaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600728</code>
	<orcid>1003194753284600728</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohsen </first_name>
	<middle_name></middle_name>
	<last_name>Basiri</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>1003194753284600729</code>
	<orcid>1003194753284600729</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
